{"title":"Synthesis of functionalized benzofuran esters through Suzuki-Miyaura cross-coupling reactions, their DFT and pharmacological studies.","authors":"Lal Khan, Muhammad Zubair","doi":"10.36721/PJPS.2025.38.5.REG.13765.1","DOIUrl":null,"url":null,"abstract":"<p><p>The Suzuki-Miyaura cross-coupling reaction was used to synthesize phenylbenzofuran-2-carboxylate derivatives (4a- 4f). The structural features of the target molecules were analyzed using two computational tools, e.g., molecular docking and DFT studies. Based on computational studies, target molecules were further screened for hemolytic and enzyme inhibitory activity, e.g., anti-urease and α-glucosidase, investigated to evaluate their biological potential. Hemolytic assay findings indicate that synthesized molecules 4a-4f are non-toxic to RBCs, while Compound (4d) and (4a) showed excellent anti-urease and α-glucosidase inhibitory activity (IC<sub>50</sub> =13.38 ±1.75µM and (IC<sub>50</sub> = 60.5 ±1.53 µM). comparable to standard drugs. DFT and molecular docking predictions of structural features supported the experimental results. Most and least reactive molecules in this series (4a-4f) are identified by comparing energies (ΔE). 4f exhibits the lowest ∆E of 3.20 eV, indicating its least stability in the synthesized series (4a-4f). In contrast, 4b displays the highest ∆E gap of 6.42 eV, suggesting its highest stability and least reactivity. In this work, computational and in vitro methodologies provided complimentary insights for effective molecular screening of drug candidates, specifically in terms of binding affinity and toxicity profiles.</p>","PeriodicalId":19971,"journal":{"name":"Pakistan journal of pharmaceutical sciences","volume":"38 5","pages":"1516-1527"},"PeriodicalIF":0.7000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan journal of pharmaceutical sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.36721/PJPS.2025.38.5.REG.13765.1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0
Abstract
The Suzuki-Miyaura cross-coupling reaction was used to synthesize phenylbenzofuran-2-carboxylate derivatives (4a- 4f). The structural features of the target molecules were analyzed using two computational tools, e.g., molecular docking and DFT studies. Based on computational studies, target molecules were further screened for hemolytic and enzyme inhibitory activity, e.g., anti-urease and α-glucosidase, investigated to evaluate their biological potential. Hemolytic assay findings indicate that synthesized molecules 4a-4f are non-toxic to RBCs, while Compound (4d) and (4a) showed excellent anti-urease and α-glucosidase inhibitory activity (IC50 =13.38 ±1.75µM and (IC50 = 60.5 ±1.53 µM). comparable to standard drugs. DFT and molecular docking predictions of structural features supported the experimental results. Most and least reactive molecules in this series (4a-4f) are identified by comparing energies (ΔE). 4f exhibits the lowest ∆E of 3.20 eV, indicating its least stability in the synthesized series (4a-4f). In contrast, 4b displays the highest ∆E gap of 6.42 eV, suggesting its highest stability and least reactivity. In this work, computational and in vitro methodologies provided complimentary insights for effective molecular screening of drug candidates, specifically in terms of binding affinity and toxicity profiles.
期刊介绍:
Pakistan Journal of Pharmaceutical Sciences (PJPS) is a peer reviewed multi-disciplinary pharmaceutical sciences journal. The PJPS had its origin in 1988 from the Faculty of Pharmacy, University of Karachi as a biannual journal, frequency converted as quarterly in 2005, and now PJPS is being published as bi-monthly from January 2013.
PJPS covers Biological, Pharmaceutical and Medicinal Research (Drug Delivery, Pharmacy Management, Molecular Biology, Biochemical, Pharmacology, Pharmacokinetics, Phytochemical, Bio-analytical, Therapeutics, Biotechnology and research on nano particles.